Allopurinol and global left myocardial function in heart failure patients
2010

Allopurinol and Heart Function in Heart Failure Patients

Sample size: 59 publication Evidence: moderate

Author Information

Author(s): Nasr Gamela, Maurice Cherine

Primary Institution: Suez Canal University

Hypothesis

Does allopurinol provide clinical and functional benefits in heart failure patients with elevated serum uric acid levels?

Conclusion

Allopurinol did not significantly improve clinical and functional outcomes in most heart failure patients, but may be beneficial for those with elevated serum uric acid.

Supporting Evidence

  • Allopurinol reduced serum uric acid by 1.5 mg/dL.
  • Patients with elevated serum uric acid responded better to allopurinol.
  • Those who improved had greater reductions in serum uric acid.

Takeaway

This study looked at whether a medicine called allopurinol helps people with heart problems. It found that it didn't help everyone, but it might help some people with high uric acid levels.

Methodology

Patients were randomized to receive either allopurinol or placebo, and their heart function was assessed using echocardiography over 36 weeks.

Potential Biases

Potential bias due to the small sample size and the specific patient population studied.

Limitations

The study did not find significant improvements in heart function for all patients, indicating that the benefits of allopurinol may be limited to specific subgroups.

Participant Demographics

59 patients with chronic heart failure due to coronary heart disease or idiopathic dilated cardiomyopathy, and 20 healthy controls.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4103/0975-3583.74262

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication